Answers are grounded in this paper and cite their sources.
Demonstrates no improvement in exercise performance from AdVEGF121 in peripheral arterial disease, suggesting local single-dose delivery is ineffective.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rajagopalan et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: